Search Results - "Flowers, M. E. D."

Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant by Watkins, B K, Horan, J, Storer, B, Martin, P J, Carpenter, P A, Flowers, M E D

Get full text

Characteristics of chronic GVHD after cord blood transplantation by Newell, L F, Flowers, M E D, Gooley, T A, Milano, F, Carpenter, P A, Martin, P J, Delaney, C

“…Most reports of chronic GVHD after cord blood transplantation (CBT) have utilized traditional diagnostic criteria. We used traditional criteria and National…”
Get full text

Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity by Aki, S Z, Inamoto, Y, Carpenter, P A, Storer, B E, Sandmaier, B M, Lee, S J, Martin, P J, Flowers, M E D

“…The 2005 NIH chronic GVHD (cGVHD) organ severity is based on the assessment of current status regardless of whether abnormalities are due to GVHD. The score…”
Get full text

Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions by Phipps, C, Lupo-Stanghellini, M T, Flowers, M E D

Get full text

Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD by Inamoto, Y, Jagasia, M, Wood, W A, Pidala, J, Palmer, J, Khera, N, Weisdorf, D, Carpenter, P A, Flowers, M E D, Jacobsohn, D, Martin, P J, Lee, S J, Pavletic, S Z

“…The 2005 National Institutes of Health (NIH) consensus criteria for chronic GVHD have set standards for reporting. Many questions, however, have arisen…”
Get full text

Secondary solid cancer screening following hematopoietic cell transplantation by Inamoto, Y, Shah, N N, Savani, B N, Shaw, B E, Abraham, A A, Ahmed, I A, Akpek, G, Atsuta, Y, Baker, K S, Basak, G W, Bitan, M, DeFilipp, Z, Gregory, T K, Greinix, H T, Hamadani, M, Hamilton, B K, Hayashi, R J, Jacobsohn, D A, Kamble, R T, Kasow, K A, Khera, N, Lazarus, H M, Malone, A K, Lupo-Stanghellini, M T, Margossian, S P, Muffly, L S, Norkin, M, Ramanathan, M, Salooja, N, Schoemans, H, Wingard, J R, Wirk, B, Wood, W A, Yong, A, Duncan, C N, Flowers, M E D, Majhail, N S

“…Hematopoietic stem cell transplant (HCT) recipients have a substantial risk of developing secondary solid cancers, particularly beyond 5 years after HCT and…”
Get full text

Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation by Thakar, M S, Kurre, P, Storb, R, Kletzel, M, Frangoul, H, Pulsipher, M A, Leisenring, W, Flowers, M E D, Sandmaier, B M, Woolfrey, A, Kiem, H-P

“…A nonmyeloablative conditioning regimen consisting of fludarabine (FLU) and 2 Gy TBI has been used extensively and with substantial engraftment success without…”
Get full text

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT by DeFilipp, Z, Duarte, R F, Snowden, J A, Majhail, N S, Greenfield, D M, Miranda, J L, Arat, M, Baker, K S, Burns, L J, Duncan, C N, Gilleece, M, Hale, G A, Hamadani, M, Hamilton, B K, Hogan, W J, Hsu, J W, Inamoto, Y, Kamble, R T, Lupo-Stanghellini, M T, Malone, A K, McCarthy, P, Mohty, M, Norkin, M, Paplham, P, Ramanathan, M, Richart, J M, Salooja, N, Schouten, H C, Schoemans, H, Seber, A, Steinberg, A, Wirk, B M, Wood, W A, Battiwalla, M, Flowers, M E D, Savani, B N, Shaw, B E

“…Metabolic syndrome (MetS) is a constellation of cardiovascular risk factors that increases the risk of cardiovascular disease, diabetes mellitus and all cause…”
Get full text

Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis by O'Donnell, P V, Eapen, M, Horowitz, M M, Logan, B R, DiGilio, A, Brunstein, C, Fuchs, E J, Flowers, M E D, Salit, R, Raj, K, Pagliuca, A, Bradstock, K, Granata, A, Castagna, L, Furst, S, Blaise, D

Get full text

Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation by CAMPREGHER, P. V, GOOLEY, T, SCOTT, B. L, MORAVEC, C, SANDMAIER, B, MARTIN, P. J, DEEG, H. J, WARREN, E. H, FLOWERS, M. E. D

“…Allogeneic hematopoietic cell transplantation (HCT) represents a potentially curative approach for patients with myelodysplastic syndromes (MDSs). While a…”
Get full text

Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation by CHEN, Chien-Shing, BOECKH, M, BENSINGER, W. I, DEEG, H. J, MARTIN, P. J, SANDERS, J. E, STORB, R, STOREK, J, WADE, J, SIADAK, M, FLOWERS, M. E. D, SULLIVAN, K. M, SEIDEL, K, CLARK, J. G, KANSU, E, MADTES, D. K, WAGNER, J. L, WITHERSPOON, R. P, ANASETTI, C, APPELBAUM, F. R

“…The incidence, etiology, outcome, and risk factors for developing pneumonia late after hematopoietic stem cell transplantation (SCT) were investigated in 1359…”
Get full text

Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease by GIACCONE, L, MARTIN, P, CARPENTER, P, MORAVEC, C, HOOPER, H, FUNKE, V. A. M, STORB, R, FLOWERS, M. E. D

“…Low-dose methotrexate (MTX) is widely used in autoimmune diseases because of its anti-inflammatory activity. We report here the results of a retrospective…”
Get full text

Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens by Sala-Torra, O, Martin, P J, Storer, B, Traina, F, Sorror, M L, Storb, R, Sandmaier, B M, Flowers, M E D

“…We previously reported a 25% incidence of serious graft-versus-host disease (GVHD) (that is, acute or chronic GVHD that caused death, lengthy hospitalization…”
Get full text

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD? by Gallo, S, Woolfrey, A E, Burroughs, L M, Storer, B E, Flowers, M E D, Hari, P, Pulsipher, M A, Heimfeld, S, Kiem, H-P, Sandmaier, B M, Storb, R

“…A total of 21 patients with severe aplastic anemia (SAA) underwent marrow transplantation from HLA-identical siblings following a standard conditioning regimen…”
Get full text

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD by Furlong, T, Martin, P, Flowers, M E D, Carnevale-Schianca, F, Yatscoff, R, Chauncey, T, Appelbaum, F R, Deeg, H J, Doney, K, Witherspoon, R, Storer, B, Sullivan, K M, Storb, R, Nash, R A

“…We evaluated the pharmacokinetics and efficacy of oral mycophenolate mofetil (MMF) for treatment of refractory GVHD. In a prospective study of acute GVHD, 9 of…”
Get full text

Recurrence of β-thalassemia major more than 20 years after HLA-identical sibling BMT treated successfully with donor lymphocyte infusion by Inamoto, Y, Yannucci, J, Storb, R F, Flowers, M E D

Get full text

Low‐dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA‐matched related donors in patients with Fanconi anaemia by Zanis‐Neto, J., Flowers, M. E. D., Medeiros, C. R., Bitencourt, M. A., Bonfim, C. M., Setúbal, D. C., Funke, V., Sanders, J., Deeg, H. J., Kiem, H. P., Martin, P., Leisenring, W., Storb, R., Pasquini, R.

“…Summary Allogeneic haematopoietic cell transplantation (HCT) is effective therapy for Fanconi anaemia (FA). FA patients do not tolerate conditioning with 200…”
Get full text

Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation by STOREK, J, DAWSON, M. A, BOECKH, M, LIM, L. C.-L, BURMAN, B. E, STEVENS-AYERS, T, VIGANEGO, F, HERREMANS, M. M. P. T, FLOWERS, M. E. D, WITHERSPOON, R. P, MALONEY, D. G

“…Allogeneic hematopoietic cell transplantation is followed by humoral immunodeficiency. We evaluated whether antibody levels can be improved by recipient…”
Get full text

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning by FLOWERS, M. E. D, TRAINA, F, STORER, B, MARIS, M, BETHGE, W. A, CARPENTER, P, APPELBAUM, F, STORB, R, SANDMAIER, B. M, MARTIN, P. J

“…The efficacy of allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning depends on the balance between the desirable…”
Get full text

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial by Mielcarek, Marco, Furlong, Terrence, Storer, Barry E, Green, Margaret L, McDonald, George B, Carpenter, Paul A, Flowers, Mary E D, Storb, Rainer, Boeckh, Michael, Martin, Paul J

“…We conducted a phase III study to test the hypothesis that initial therapy with "lower dose" prednisone is effective and safe for patients with newly diagnosed…”
Get full text